Review paper<br>Metabolic syndrome in patients with polycystic ovary syndrome

Agnieszka Kosk; Irina Kowalska

eISSN: 2084-9877
ISSN: 1896-9666

Przegląd Kardiodiabetologiczny/Cardio-Diabetological Review

Current issue Archive About the journal Contact Instructions for authors

3/2009
vol. 4

Send email

Copy url:

abstract:

Review paper
Metabolic syndrome in patients with polycystic ovary syndrome

Agnieszka Kosk

,

Irina Kowalska

Przegląd Kardiodiabetologiczny 2009; 4 (3): 142–146

Online publish date: 2009/10/22

View full text Get citation

Metabolic syndrome consists of some metabolic abnormalities including visceral obesity, decreased HDL cholesterol, elevated triglycerides, elevated blood pressure and hyperglycaemia and is associated with an increased risk of type 2 diabetes, atherosclerosis and cardiovascular diseases. Polycystic ovary syndrome is the most common causes of infertility affecting 5-10% women in reproductive age. The major clinical manifestations are chronic anovulation, menstrual abnormalities and hyperandrogenism. Patients with polycystic ovary syndrome have also higher prevalence of type 2 diabetes mellitus and cardiovascular diseases. Metabolic syndrome and polycystic ovary syndrome share common pathogenetic factor that is insulin resistance. The early identification of the components of metabolic syndrome in patients with polycystic ovary syndrome leads to prevention of cardio-vascular diseases.

keywords:

Review paperMetabolic syndrome in patients with polycystic ovary syndrome

Agnieszka Kosk , Irina Kowalska

metabolic syndrome, polycystic ovary syndrome

Review paper
Metabolic syndrome in patients with polycystic ovary syndrome

Agnieszka Kosk

,

Irina Kowalska